Abstract
Clinical trials often require homogeneous treatment plans. Many institutions, however, have begun using heterogeneous plans. Is it possible to satisfy the requirements of such a protocol while achieving the superior accuracy of heterogeneous treatment planning? At the University of Texas M. D. Anderson Cancer Center, we currently use conformal treatment planning with heterogeneities for thoracic cancers. This paper describes a procedure that has been developed to satisfy the requirements of a homogeneous protocol, such as RTOG 98-01 (A Phase III Study of Amifostine mucosal protection), while maintaining accuracy in treatment planning.
Citation Formats
Brooks, Chris, Starkschall, George, Famiglietti, Robin, Cox, James, Frank, Steven, Komaki, Ritsuko, Zhongxing, Liao, Stevens, Craig, and Forster, Kenneth.
Heterogeneous planning for homogeneous protocols.
United States: N. p.,
2004.
Web.
doi:10.1016/j.meddos.2004.03.006.
Brooks, Chris, Starkschall, George, Famiglietti, Robin, Cox, James, Frank, Steven, Komaki, Ritsuko, Zhongxing, Liao, Stevens, Craig, & Forster, Kenneth.
Heterogeneous planning for homogeneous protocols.
United States.
https://doi.org/10.1016/j.meddos.2004.03.006
Brooks, Chris, Starkschall, George, Famiglietti, Robin, Cox, James, Frank, Steven, Komaki, Ritsuko, Zhongxing, Liao, Stevens, Craig, and Forster, Kenneth.
2004.
"Heterogeneous planning for homogeneous protocols."
United States.
https://doi.org/10.1016/j.meddos.2004.03.006.
@misc{etde_20619430,
title = {Heterogeneous planning for homogeneous protocols}
author = {Brooks, Chris, Starkschall, George, Famiglietti, Robin, Cox, James, Frank, Steven, Komaki, Ritsuko, Zhongxing, Liao, Stevens, Craig, and Forster, Kenneth}
abstractNote = {Clinical trials often require homogeneous treatment plans. Many institutions, however, have begun using heterogeneous plans. Is it possible to satisfy the requirements of such a protocol while achieving the superior accuracy of heterogeneous treatment planning? At the University of Texas M. D. Anderson Cancer Center, we currently use conformal treatment planning with heterogeneities for thoracic cancers. This paper describes a procedure that has been developed to satisfy the requirements of a homogeneous protocol, such as RTOG 98-01 (A Phase III Study of Amifostine mucosal protection), while maintaining accuracy in treatment planning.}
doi = {10.1016/j.meddos.2004.03.006}
journal = []
issue = {2}
volume = {29}
journal type = {AC}
place = {United States}
year = {2004}
month = {Jun}
}
title = {Heterogeneous planning for homogeneous protocols}
author = {Brooks, Chris, Starkschall, George, Famiglietti, Robin, Cox, James, Frank, Steven, Komaki, Ritsuko, Zhongxing, Liao, Stevens, Craig, and Forster, Kenneth}
abstractNote = {Clinical trials often require homogeneous treatment plans. Many institutions, however, have begun using heterogeneous plans. Is it possible to satisfy the requirements of such a protocol while achieving the superior accuracy of heterogeneous treatment planning? At the University of Texas M. D. Anderson Cancer Center, we currently use conformal treatment planning with heterogeneities for thoracic cancers. This paper describes a procedure that has been developed to satisfy the requirements of a homogeneous protocol, such as RTOG 98-01 (A Phase III Study of Amifostine mucosal protection), while maintaining accuracy in treatment planning.}
doi = {10.1016/j.meddos.2004.03.006}
journal = []
issue = {2}
volume = {29}
journal type = {AC}
place = {United States}
year = {2004}
month = {Jun}
}